Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
Rivaroxaban (Xarelto)
Cat No.
CEI-0243
Description
Rivaroxaban (Xarelto, BAY 59-7939)can inhibit Factor Xa with IC50 of 0.7 nM.
CAS No.
366789-02-8
Molecular Weight
435.88
Purity
>99%
Storage
2 years at -20 centigrade
Targets
Factor Xa
Molecular Formula
C19H18ClN3O5S
Chemical Name
(S)-5-chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide
Solubility
DSMO 87 mg/mL Water
In vitro
Rivaroxaban is an oral, direct inhibitor of Factor Xa (FXa), being developed for the prevention and treatment of arterial and venous thrombosis with a Ki of 0.4 nM. Rivaroxaban exhibits high permeability and polarized transport across Caco-2 cells as a substrate of the P-gp, but exhibits no inhibitory effect on P-gp-mediated drug transport up to concentrations of 100 uM in vitro.
In vivo
Rivaroxaban reduces venous thrombosis in a dose dependent manner (ED50 0.1 mg/kg i.v.) in a rat venous stasis model. Rivaroxaban reduces arterial thrombus formation in an arteriovenous (AV) shunt in rats (ED50 5.0 mg/kg p.o.) and rabbits (ED50 0.6 mg/kg p.o.).
Download
Download Datasheet